Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer
Lung Cancer: Targets and Therapy · 2010
DOI: 10.2147/lctt.s10167 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Lung Cancer: Targets and Therapy, 2010. Verfasst von Serena Ricciardi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic-Oncology Unit 1st, Lung Diseases Department, San Camillo-Forlanini High Specialization Hospitals, Rome, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thoracic-Oncology Unit 1st, Lung Diseases Department, San Camillo-Forlanini High Specialization Hospitals, Rome, Italy.
- Sperimental Medicine Department, La Sapienza University, Rome, Italy.
Zitieren
APA
Ricciardi, S., Tomao, S., & de Marinis, F. (2010). Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer. Lung Cancer: Targets and Therapy. https://doi.org/10.2147/lctt.s10167
Vancouver
Ricciardi S, Tomao S, de Marinis F. Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer. Lung Cancer: Targets and Therapy. 2010. doi:10.2147/lctt.s10167
BibTeX
@article{Ricciardi2010,
author = {Ricciardi, Serena and Tomao, Silverio and de Marinis, Filippo},
title = {Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer},
journal = {Lung Cancer: Targets and Therapy},
year = {2010},
doi = {10.2147/lctt.s10167}
}
EUVIMED